Recurrent WHO Grade 3 Glioma
specificThe reemergence of WHO grade 4 glioma after a period of remission.
11
Centers
11
Active Trials
—
Cancer Funding
Top Centers for Recurrent WHO Grade 3 Glioma(11)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 54.5 |
| 2 | Siteman Cancer CenterSt. Louis, MO NCI Comprehensive Active Research Program | 54.5 |
| 3 | Herbert Irving Comprehensive Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 54.5 |
| 4 | NCI Comprehensive Active Research Program | 54.5 |
| 5 | NCI Comprehensive Active Research Program | 54.5 |
| 6 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 54.5 |
| 7 | NCI Comprehensive Active Research Program | 54.5 |
| 8 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 54.5 |
| 9 | NCI Clinical Active Research Program | 54.5 |
| 10 | University of Illinois Cancer CenterChicago, IL Active Research Program | 54.5 |
| 11 | Cancer Center at IllinoisUrbana, IL Active Research Program | 54.5 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →